半亩花田冲刺「港股国货个护第一股」：2025年前三季度净利润同比增超197%

Core Viewpoint - Banmu Huatian is positioned to become the leading domestic personal care brand in Hong Kong's stock market, with a comprehensive product range and strong market presence in body, hair, and facial care categories [2][3]. Company Overview - Founded in 2010, Banmu Huatian has evolved from a single star product to a full-category brand in skin and personal care, achieving leading positions in multiple categories within the Chinese market [3]. - As of 2024, Banmu Huatian is the top domestic brand for body lotion, body scrub, and facial cleansing mousse based on retail sales [3]. Product Development - The company has successfully launched key products such as body scrubs and body lotions, with cumulative sales of approximately 37.7 million bottles for body scrubs and 56.9 million bottles for body lotions by September 30, 2025 [5]. - The whitening body lotion has sold around 8 million bottles since its launch [5]. - Banmu Huatian has expanded its product lines into hair and facial care, with hair care revenue growing by 496.1% year-on-year in the first three quarters of 2025 [5]. Sales Channels - The company has transitioned from a single online channel to a comprehensive omnichannel strategy, utilizing platforms like Tmall, Douyin, and JD for brand building and customer engagement [6]. - As of September 30, 2025, Banmu Huatian has 17 million registered online members [6]. Financial Performance - Banmu Huatian's revenue reached 1.199 billion yuan in 2023 and is projected to grow to 1.499 billion yuan in 2024, reflecting a year-on-year increase of 25% [10]. - In the first three quarters of 2025, revenue surged by 76.7% to 1.895 billion yuan compared to the same period in 2024, with adjusted net profit increasing by 197.2% to 148 million yuan [10]. Research and Development - The company invested 28.6 million yuan and 32 million yuan in R&D in 2023 and 2024, respectively, with a 25.91% increase in R&D spending in the first three quarters of 2025 [9]. - Banmu Huatian has established a comprehensive R&D system, focusing on raw material development, technology transfer, and product efficacy verification [8]. Future Plans - The funds raised from the IPO will be allocated to channel development, product marketing, enhancing R&D capabilities, building a diverse global talent pool, and improving digital infrastructure [11].